Literature DB >> 24865669

Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome.

Amanda Ryan1, Shunping Wang, Ruben Alvero, Alex J Polotsky.   

Abstract

PURPOSE: To determine if etiology of infertility modifies the relationship between the duration of ovarian stimulation and success during assisted reproductive technology (ART) cycles.
METHODS: A prospectively collected database was analyzed in an academic infertility practice. Eight hundred and twelve infertile women undergoing their initial fresh embryo, non-donor in vitro fertilization (IVF) or Intracytoplasmic Sperm Injection ICSI) cycle between January 1999 and December 2010 were evaluated. Clinical pregnancy was the main outcome measured.
RESULTS: Out of 663 cycles resulting in oocyte retrieval, 299 produced a clinical pregnancy (45.1%). Women who achieved a clinical pregnancy had a significantly shorter stimulation length (11.9 vs. 12.1 days, p = 0.047). Polycystic ovary syndrome (PCOS) was the only etiology of infertility that was significantly associated with a higher chance for clinical pregnancy and was a significant confounder for the association of duration and success of treatment. Women with 13 days or longer of stimulation had a 34 % lower chance of clinical pregnancy as compared to those who had a shorter cycle (OR 0.66, 95% CI:0.46-0.95) after adjustment for age, ovarian reserve, number of oocytes retrieved, embryos transferred and PCOS diagnosis.
CONCLUSION: Prolonged duration of stimulation is associated with decreased ART success for all couples, except for women with PCOS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24865669      PMCID: PMC4096873          DOI: 10.1007/s10815-014-0253-9

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  23 in total

1.  The status of public reporting of clinical outcomes in assisted reproductive technology.

Authors:  Vitaly A Kushnir; Andrea Vidali; David H Barad; Norbert Gleicher
Journal:  Fertil Steril       Date:  2013-06-10       Impact factor: 7.329

Review 2.  Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements.

Authors:  R Homburg; C M Howles
Journal:  Hum Reprod Update       Date:  1999 Sep-Oct       Impact factor: 15.610

3.  Ovarian stimulation in previous failures from in-vitro fertilization: distinction of two groups of poor responders.

Authors:  T Tanbo; T Abyholm; T Bjøro; P O Dale
Journal:  Hum Reprod       Date:  1990-10       Impact factor: 6.918

Review 4.  Environmental and occupational factors affecting fertility and IVF success.

Authors:  Edward V Younglai; Alison C Holloway; Warren G Foster
Journal:  Hum Reprod Update       Date:  2004-12-15       Impact factor: 15.610

5.  In-vitro fertilization in infertile women with the polycystic ovarian syndrome.

Authors:  P O Dale; T Tanbo; T Abyholm
Journal:  Hum Reprod       Date:  1991-02       Impact factor: 6.918

Review 6.  Assisted reproduction in the treatment of polycystic ovarian syndrome.

Authors:  Bulent Urman; Bulent Tiras; Kayhan Yakin
Journal:  Reprod Biomed Online       Date:  2004-04       Impact factor: 3.828

7.  A comparative study of fixed-dose, step-down, and low-dose step-up regimens of human menopausal gonadotropin for patients with polycystic ovary syndrome.

Authors:  K Andoh; H Mizunuma; X Liu; T Kamijo; K Yamada; Y Ibuki
Journal:  Fertil Steril       Date:  1998-11       Impact factor: 7.329

8.  Prognostic assessment of female fecundity.

Authors:  D Navot; Z Rosenwaks; E J Margalioth
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

9.  Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

Authors:  Joop S E Laven; Annemarie G M G J Mulders; Jenny A Visser; Axel P Themmen; Frank H De Jong; Bart C J M Fauser
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

10.  Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries.

Authors:  K Hardy; F M Robinson; T Paraschos; R Wicks; S Franks; R M Winston
Journal:  Hum Reprod       Date:  1995-08       Impact factor: 6.918

View more
  8 in total

1.  The duration of gonadotropin stimulation does not alter the clinical pregnancy rate in IVF or ICSI cycles.

Authors:  N Purandare; G Emerson; C Kirkham; C Harrity; D Walsh; E Mocanu
Journal:  Ir J Med Sci       Date:  2016-11-07       Impact factor: 1.568

2.  Association between the proportion of dominant follicles and oocyte developmental competence.

Authors:  Yi Li; Rui-Qi Li; Song-Bang Ou; Ling Ren; Ning-Feng Zhang; Li-Na Wei; Qing-Xue Zhang; Dong-Zi Yang
Journal:  J Assist Reprod Genet       Date:  2014-09-17       Impact factor: 3.412

3.  Characteristics and outcomes of in vitro fertilization in different phenotypes of polycystic ovary syndrome.

Authors:  Selçuk Selçuk; Enis Özkaya; Ahmet Eser; Melda Kuyucu; Hüseyin Tayfun Kutlu; Belgin Devranoğlu; Kenan Sofuoğlu; Vedat Erkan Dayıcıoğlu
Journal:  Turk J Obstet Gynecol       Date:  2016-03-10

4.  Factors Associated with In Vitro Fertilization Live Birth Outcome: A Comparison of Different Classification Methods.

Authors:  Payam Amini; Fariba Ramezanali; Mahta Parchehbaf-Kashani; Saman Maroufizadeh; Reza Omani-Samani; Azadeh Ghaheri
Journal:  Int J Fertil Steril       Date:  2021-03-11

5.  Effects of half-dose and full-dose GnRH antagonists on IVF-ET outcomes: a retrospective study.

Authors:  Yingge Zhao; Fang Lian; Shan Xiang; Yi Yu; Conghui Pang; Yue Qiu
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-27       Impact factor: 3.007

6.  Association Between the Ratio of Ovarian Stimulation Duration to Original Follicular Phase Length and In Vitro Fertilization Outcomes: A Novel Index to Optimise Clinical Trigger Time.

Authors:  Xinyang Zhao; Xu Zhang; Shanshan Wu; Jichun Tan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-25       Impact factor: 6.055

Review 7.  Ovarian Stimulation in Assisted Reproductive Technology Cycles for Varied Patient Profiles: An Indian Perspective.

Authors:  Padma Rekha Jirge; Madhuri Milind Patil; Rohit Gutgutia; Jatin Shah; Mridubhashini Govindarajan; Varsha Samson Roy; Nalini Kaul-Mahajan; Faddy I Sharara
Journal:  J Hum Reprod Sci       Date:  2022-06-30

8.  Influence of body mass index and polycystic ovarian syndrome on ICSI/IVF treatment outcomes: A study conducted in Pakistani women.

Authors:  Rehana Rehman; Mohsin Mehmood; Rabiya Ali; Saeeda Shaharyar; Faiza Alam
Journal:  Int J Reprod Biomed       Date:  2018-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.